Link Pharma Chem Intrinsic Value

LINKPH • Chemicals

Link Pharma Chem (LINKPH) median intrinsic value is ₹52.00 from 4 valuation models (range ₹13–₹70), vs current price ₹28.54 — +82.2% upside (Trading Below Calculated Value), margin of safety 45.1%. For current market price and key ratios, visit Link Pharma Chem stock price NSE .

Current Stock Price
₹28.54
Primary Intrinsic Value
₹32.50
Market Cap
₹11.4 Cr
+82.2% Upside
Median Value
₹52.00
Value Range
₹13 - ₹70
Assessment
Trading Below Calculated Value
Safety Margin
45.1%

LINKPH Valuation Methods Summary — DCF, Graham Number & P/E

Link Pharma Chem intrinsic value across 4 models vs current price ₹28.54 — upside/downside and value range per method. Browse LINKPH financial statements for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹32.50 ₹29.25 - ₹35.75 +13.9% Book Value/Share: ₹32.50, P/B: 1.0x
Revenue Multiple Method revenue ₹52.00 ₹46.80 - ₹57.20 +82.2% Revenue/Share: ₹65.00, P/S: 0.8x
EBITDA Multiple Method earnings ₹13.38 ₹12.04 - ₹14.72 -53.1% EBITDA: ₹1.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹69.63 ₹55.70 - ₹83.56 +144.0% CF Growth: 5.0%, Discount: 15%
Method Types: Earnings Asset DCF Growth Dividend Conservative

LINKPH Intrinsic Value vs Market Price — All Valuation Models

Link Pharma Chem fair value range ₹13–₹70 vs current market price ₹28.54 across 4 valuation models. Compare with LINKPH intrinsic value calculation to assess whether the stock is under or overvalued.

LINKPH Intrinsic Value Analysis — Undervalued or Overvalued?

Link Pharma Chem median intrinsic value ₹52.00, current price ₹28.54 — Trading Below Calculated Value by 82.2%, margin of safety 45.1%.

What is the intrinsic value of LINKPH?

Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Link Pharma Chem (LINKPH) is ₹52.00 (median value). With the current market price of ₹28.54, this represents a +82.2% variance from our estimated fair value.

The valuation range spans from ₹13.38 to ₹69.63, indicating ₹13.38 - ₹69.63.

Is LINKPH undervalued or overvalued?

Based on our multi-method analysis, Link Pharma Chem (LINKPH) appears to be trading below calculated value by approximately 82.2%.

LINKPH Financial Health — Key Ratios vs Industry Benchmarks

Link Pharma Chem financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 11.00 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Debt to Equity Ratio 1.77 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Return on Equity -7.7% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin 3.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 1.13x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

LINKPH Cash Flow Quality — Operating & Free Cash Flow

Link Pharma Chem operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹3 Cr ₹3 Cr Positive Free Cash Flow 8/10
March 2024 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2023 ₹-2 Cr ₹-2 Cr Negative Cash Flow 3/10
March 2022 ₹-1 Cr ₹-4 Cr Negative Cash Flow 3/10
March 2021 ₹5 Cr ₹4 Cr Positive Free Cash Flow 8/10